Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bristol-Myers Squibb

47.84
-0.1100-0.23%
Post-market: 47.880.0400+0.08%19:59 EDT
Volume:12.79M
Turnover:614.75M
Market Cap:97.36B
PE:17.91
High:48.60
Open:48.05
Low:47.73
Close:47.95
Loading ...

Bristol-Myers Squibb’s Strategic Partnership with BioNTech: A Promising Future for BNT327 in Immunology Therapy

TIPRANKS
·
Yesterday

Bristol-Myers Squibb Files Initial Beneficial Ownership Statement for Wendy Short Bartie, EVP Corporate Affairs

Reuters
·
Yesterday

Trump's Tax Bill Is Testing the Dollar. This Red Flag Matters More. -- Barrons.com

Dow Jones
·
03 Jun

BioNTech Jumps Another 3.7% After Surging 18% as Bristol-Myers to Pay BioNTech Up to $11.1 Billion in Cancer Deal

Tiger Newspress
·
03 Jun

Post-Bell | U.S. Stocks Close Higher; Tesla Drops 1%; Nvidia Gains 2%; Cleveland-Cliffs Surges 23%; Applied Digital Soars 48%

Tiger Newspress
·
03 Jun

Sector Update: Health Care Stocks End Higher Late Afternoon

MT Newswires Live
·
03 Jun

HSBC Raises Bristol-Myers Squibb's Price Target to $50 From $47

MT Newswires Live
·
03 Jun

Bristol deal takes out ‘key’ potential buyer of Summit Therapeutics, says Truist

TIPRANKS
·
03 Jun

Bristol-Myers Squibb (BMY) Receives a Hold from Citi

TIPRANKS
·
03 Jun

BioNTech Rockets 17% as Bristol-Myers to Pay BioNTech Up to $11.1 Billion in Cancer Deal

Bloomberg
·
02 Jun

BUZZ-U.S. STOCKS ON THE MOVE-Xilio Therapeutics, Red Rock Resorts, Kymera

Reuters
·
02 Jun

Balanced Outlook on Bristol-Myers Squibb Amid Promising Oncology Pipeline and Market Challenges

TIPRANKS
·
02 Jun

BioNTech, Bristol Myers partner to co-develop BNT327

TIPRANKS
·
02 Jun

BioNTech SE and Bristol Myers Squibb Announce Global Partnership for Development and Commercialization of Antibody Candidate BNT327 in Solid Tumors

Reuters
·
02 Jun

Bristol Myers Says BioNTech Also Eligible to Receive up to $7.6 Billion in Additional Milestone Payments

THOMSON REUTERS
·
02 Jun

BRISTOL MYERS AND BIONTECH TO PARTNER TO DEVELOP AND COMMERCIALIZE CANCER DRUG BNT327

THOMSON REUTERS
·
02 Jun

Bristol Myers Says Will Pay BioNTech $1.5 Billion Upfront to Partner on Cancer Drug

THOMSON REUTERS
·
02 Jun

Bristol Myers and BioNTech Will Share Profits, Losses and Development and Manufacturing Costs for Bnt327

THOMSON REUTERS
·
02 Jun

BMO Capital Reaffirms Their Hold Rating on Bristol-Myers Squibb (BMY)

TIPRANKS
·
31 May

Bristol Myers Squibb Co. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
30 May